文献速递心脑血管急症

伊朗急诊科急性缺血性卒中患者的治疗延迟:一项回顾性病历审查

Treatment Delays for Patients With Acute Ischemic Stroke in an Iranian Emergency Department: A Retrospective Chart Review.
PubMed 文献 · Ann Emerg Med · 2018-10-11
一句话结论80.2%的急性缺血性卒中患者因就诊延迟超过4.5小时等原因不符合静脉r-tPA条件,符合条件者入院至给药中位时间69分钟。

该研究对伊朗西北部一家三级学术医疗中心急诊科2017年3月21日至6月21日收治的394例急性缺血性卒中患者进行回顾性病历审查,评估治疗延迟程度、影响因素及卒中救治的主要障碍。主要结局为已识别的治疗延迟和失去静脉重组组织型纤溶酶原激活剂(r-tPA)资格的原因。结果显示80.2%的患者不符合静脉r-tPA条件,最常见原因为症状发作后到达急诊超过4.5小时(71.82%,n=283);在19.8%启动卒中代码的患者中,仅5.3%接受了静脉r-tPA。符合r-tPA条件者从到达至急诊住院医师首次接诊、通知急性卒中团队、神经科住院医师到场及CT判读的平均时间均短于失去溶栓资格者,平均入院至给药时间为69分钟(四分位距46至91分钟)。作者认为,对潜在符合条件患者,其急诊和急性卒中团队表现良好,达到既定的院内关键时间目标,但对大多数不适合溶栓的患者临床表现不佳。

要点

  • 80.2%的急性缺血性卒中患者不符合静脉r-tPA条件,最常见原因为症状发作后超过4.5小时才到达急诊(71.82%,n=283)。
  • 在19.8%启动卒中代码的患者中,仅5.3%接受了静脉r-tPA。
  • 平均入院至给药时间为69分钟(四分位距46至91分钟)。
  • 符合r-tPA条件者从到达至急诊住院医师首次接诊、通知急性卒中团队、神经科住院医师到场及CT判读的平均时间均短于失去溶栓资格者。

适用人群与场景

  • 2017年3月21日至6月21日转诊至伊朗西北部一家三级学术医疗中心急诊科的394例急性缺血性卒中患者。

研究设计与关键结果

  • 研究类型为回顾性病历审查,样本量394例,单中心,人群为急性缺血性卒中患者。
  • 主要结局为已识别的治疗延迟和失去静脉r-tPA资格的原因;80.2%的患者不符合静脉r-tPA条件,最常见原因为症状发作后超过4.5小时到达急诊(71.82%,n=283)。
  • 19.8%的患者启动了卒中代码,其中仅5.3%接受了静脉r-tPA。
  • 平均入院至给药时间为69分钟(四分位距46至91分钟)。
  • 符合静脉r-tPA条件者从到达至急诊住院医师首次接诊、通知急性卒中团队、神经科住院医师到场及CT判读的平均时间均短于失去纤溶治疗资格者。

证据类型、等级与局限

  • 证据类型:回顾性病历审查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,其急诊和急性卒中团队对潜在符合条件患者表现良好,达到既定的院内关键时间目标,但对大多数不适合纤溶治疗的患者临床表现不佳。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

STUDY OBJECTIVE: We evaluate the extent and nature of treatment delays and the contributing factors influencing them for patients with acute ischemic stroke, as well as main barriers to stroke care in an Iranian emergency department (ED).

METHODS: A retrospective chart review was conducted on 394 patients with acute ischemic stroke who were referred to the ED of a tertiary academic medical center in northwest Iran from March 21 to June 21, 2017. The steps of this review process included instrument development, medical records retrieval, data extraction, and data verification. Primary outcomes were identified treatment delays and causes of loss of eligibility for intravenous recombinant tissue plasminogen activator (r-tPA).

RESULTS: Of patients with acute ischemic stroke, 80.2% did not meet intravenous r-tPA eligibility; the most common cause was delayed (>4.5 hours) ED arrival after symptom onset (71.82%; n=283). Of 19.8% of subjects for whom the stroke code was activated, intravenous r-tPA was administered in only 5.3%. The average time from patients' arrival to first emergency medicine resident visit, notification of acute stroke team, presence of neurology resident, and computed tomography scan interpretation was lower for patients who met criteria of intravenous r-tPA than for those who lost eligibility for fibrinolytic therapy. The average door-to-needle time was 69 minutes (interquartile range 46 to 91 minutes).

CONCLUSION: Our ED and acute stroke team had a favorable clinical performance meeting established critical time goals of inhospital care for potentially eligible patients, but a poor clinical performance for the majority of patients who were not candidates for fibrinolytic therapy.

来源:Ann Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Hassankhani H, Soheili A, Vahdati SS, et al. Treatment Delays for Patients With Acute Ischemic Stroke in an Iranian Emergency Department: A Retrospective Chart Review. Ann Emerg Med. 2018. PMID: 30318375. doi:10.1016/j.annemergmed.2018.08.435

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。